Jorge Brito Pereira e Rui Bello da Silva assessoram a venda da biofarmacêutica GenIbet à multinacional Recipharm
14/02/2022 | 
Jorge Brito Pereira and Rui Bello da Silva advised on the sale of biopharmaceutical company GenIbet to multinational Recipharm
14 de fevereiro 2022
Jorge Brito Pereira, partner of the firm, coordinated the sale of biopharmaceutical company GenIbet to multinational Recipharm. Alongside him was the senior associate, Rui Bello da Silva.
The transaction was announced both on Advocatus and Iberian Lawyer.